Kenji Tsukigawa Selected Research

zinc protoporphyrin

4/2016	A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy--Problems, Solutions, and Prospects.
1/2016	Styrene-maleic acid-copolymer conjugated zinc protoporphyrin as a candidate drug for tumor-targeted therapy and imaging.
1/2015	Effect of different chemical bonds in pegylation of zinc protoporphyrin that affects drug release, intracellular uptake, and therapeutic effect in the tumor.
2/2013	Micelles of zinc protoporphyrin conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer for imaging and light-induced antitumor effects in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenji Tsukigawa Research Topics

Disease

9	Neoplasms (Cancer) 03/2022 - 03/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022
1	Mycoses (Diseases, Fungus) 01/2022
1	Gout 01/2021
1	Hemorrhage 01/2021
1	Thrombosis (Thrombus) 04/2016
1	Hypertension (High Blood Pressure) 04/2016
1	Neoplasm Metastasis (Metastasis) 04/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 02/2013
1	Reperfusion Injury 12/2011
1	Ischemia 12/2011

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 12/2016 - 03/2012
4	zinc protoporphyrinIBA 04/2016 - 02/2013
3	Heme Oxygenase-1IBA 01/2016 - 12/2011
2	PolymersIBA 12/2016 - 04/2016
2	Biological ProductsIBA 12/2016 - 01/2015
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2016 - 01/2016
2	Styrene (Styrol)IBA 02/2016 - 01/2016
2	maleic acid (maleate)IBA 02/2016 - 01/2016
2	MicellesIBA 02/2016 - 02/2013
2	Therapeutic UsesIBA 01/2015 - 02/2013
2	Hemin (Panhematin)FDA Link 03/2012 - 12/2011
1	Nateglinide (Starlix)FDA LinkGeneric 03/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2022
1	CaspasesIBA 03/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2022
1	AnnexinsIBA 03/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2022
1	EchinocandinsIBA 01/2022
1	AnticoagulantsIBA 01/2021
1	nafamostatIBA 01/2021
1	BenzbromaroneIBA 01/2021
1	N-(2-hydroxypropyl)methacrylamideIBA 12/2016
1	Angiotensin IIIBA 04/2016
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2016
1	ProstaglandinsIBA 04/2016
1	BradykininIBA 04/2016
1	ElementsIBA 04/2016
1	XenonIBA 04/2016
1	Nitroglycerin (Dynamite)FDA LinkGeneric 04/2016
1	Cisplatin (Platino)FDA LinkGeneric 02/2016
1	AmidesIBA 01/2016
1	copoly(styrene-maleic acid)-zinc protoporphyrinIBA 01/2016
1	Antineoplastic Agents (Antineoplastics)IBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2015
1	EsterasesIBA 01/2015
1	EstersIBA 01/2015
1	Serine (L-Serine)FDA Link 01/2015
1	Cysteine Proteases (Cysteine Protease)IBA 01/2015
1	hydroxypropyl methacrylateIBA 02/2013
1	DuxonIBA 02/2013
1	SolutionsIBA 02/2013
1	Singlet OxygenIBA 02/2013
1	AlbuminsIBA 03/2012
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2012
1	Carbon MonoxideIBA 03/2012
1	Evans Blue (Blue, Evans)FDA Link 03/2012
1	tricarbonyldichlororuthenium (II) dimerIBA 03/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2011

Therapy/Procedure

3	Therapeutics 04/2016 - 02/2013
2	Photochemotherapy (Photodynamic Therapy) 04/2016 - 01/2016
1	Renal Dialysis (Hemodialysis) 01/2021